Page last updated: 2024-09-03

efaproxiral and Breast Cancer

efaproxiral has been researched along with Breast Cancer in 6 studies

Research

Authors	Studies
Charpentier, MM	1
Boyd, AP; Cagnoni, PJ; Chang, EL; Fortin, A; Kresl, JJ; Mercier, JP; Nabid, A; Senzer, N; Shaw, E; Stea, B; Suh, JH	1
Cannell, E	1
Engel, RH; Kaklamani, VG	1
Craig, M; Hackman, J; May, J; Pintér, T; Shaw, E; Stea, B; Steffen, RP; Suh, JH	1
Hackman, J; Nabid, A; Scott, C; Stea, B; Suh, J	1

2 review(s) available for efaproxiral and Breast Cancer

Article	Year
Efaproxiral: a radiation enhancer used in brain metastases from breast cancer. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:12 Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Propionates; Radiation-Sensitizing Agents	2005
Role of efaproxiral in metastatic brain tumors. Expert review of anticancer therapy, 2006, Volume: 6, Issue:4 Topics: Aniline Compounds; Animals; Brain Neoplasms; Breast Neoplasms; Humans; Propionates	2006

3 trial(s) available for efaproxiral and Breast Cancer

Article	Year
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-01, Volume: 24, Issue:1 Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents	2006
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases. British journal of cancer, 2006, Jun-19, Volume: 94, Issue:12 Topics: Aniline Compounds; Antisickling Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Male; Middle Aged; Prognosis; Propionates; Survival Analysis	2006
Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases. American journal of clinical oncology, 2007, Volume: 30, Issue:6 Topics: Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Cranial Irradiation; Female; Humans; Middle Aged; Oxygen; Propionates; Quality of Life; Quality-Adjusted Life Years; Radiation Dosage; Radiation-Sensitizing Agents; Survival Rate	2007

1 other study(ies) available for efaproxiral and Breast Cancer

Article	Year
New hope for old drug in patients with brain metastases. The Lancet. Oncology, 2006, Volume: 7, Issue:2 Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Propionates; Radiation-Sensitizing Agents	2006